ESR1 and triple-negative breast carcinoma: Such tumor evolution has been extensively documented in matched primary and metastatic renal cell carcinomas [23] and has been examined at the sequence level in triple-negative breast cancer [24], but has not been studied extensively in ER+ breast cancer.